Derris Scandens Benth Extract VS Naproxen in Knee OA
Maneno muhimu
Kikemikali
Tarehe
Imethibitishwa Mwisho: | 05/31/2009 |
Iliyowasilishwa Kwanza: | 07/17/2007 |
Uandikishaji uliokadiriwa Uliwasilishwa: | 07/17/2007 |
Iliyotumwa Kwanza: | 07/18/2007 |
Sasisho la Mwisho Liliwasilishwa: | 01/10/2010 |
Sasisho la Mwisho Lilichapishwa: | 01/12/2010 |
Tarehe halisi ya kuanza kwa masomo: | 06/30/2007 |
Tarehe ya Kukamilisha Msingi iliyokadiriwa: | 02/28/2009 |
Tarehe ya Kukamilisha Utafiti: | 02/28/2009 |
Hali au ugonjwa
Uingiliaji / matibabu
Drug: Derris Scandens Benth
Drug: naproxen
Awamu
Vikundi vya Arm
Mkono | Uingiliaji / matibabu |
---|---|
Active Comparator: naproxen Naproxen 500 mg/day for 4 weeks | Drug: naproxen Naproxen 500 mg/day for 4 weeks |
Experimental: Derris Scandens Benth Derris Scandens Benth | Drug: Derris Scandens Benth Derris scandens Benth extracts (oral) 400 mg twice per day for 4 weeks |
Vigezo vya Kustahiki
Zama zinazostahiki Kujifunza | 50 Years Kwa 50 Years |
Jinsia Inastahiki Kujifunza | All |
Hupokea Wajitolea wa Afya | Ndio |
Vigezo | Inclusion Criteria: - Age >=50 yr - Known case of primary knee osteoarthritis - WOMAC pain subscale (item1) >= 5 - signed informed consent Exclusion Criteria: - hypersensitive to NSAIDs - history of peptic ulcer or melena - unable to walk , i.e. patient with severe spinal stenosis, myocardial infarction - history of intra-articular injection of knee within 3 months - status post knee replacement |
Matokeo
Hatua za Matokeo ya Msingi
1. WOMAC score [2, 4 weeks]
Hatua za Matokeo ya Sekondari
1. 6-minute walk, Quality of Life, adverse event [2, 4 weeks]